NCT00634647 2018-10-02
Satraplatin and Prednisone to Treat Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
9 trialsNCT01259479 2018-07-05
Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00499694 2018-06-12
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT01289067 2018-02-13
Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT00473720 2013-01-23
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
Yale University
Phase 1 Completed
NCT00069745 2012-08-07
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
Agennix
Phase 3 Completed
NCT00370383 2012-08-07
A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)
Agennix
Phase 2 Completed
NCT00268970 2012-04-30
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
Agennix
Phase 2 Completed
NCT00265655 2012-03-28
Satraplatin for Patients With Metastatic Breast Cancer (MBC)
Agennix
Phase 2 Completed